News
INBRAIN Neuroelectronics Raises $50M Series B to Advance Graphene-Based Brain-Computer Interface Technology
INBRAIN Neuroelectronics, a brain-computer interface therapeutics (BCI-Tx) company developing graphene-based neural technologies, today announced the close of a $50 million Series B financing round. The
Inbiomotion and SPA – Società Prodotti Antibiotici (SPA Farma) sign an exclusive agreement for MAF Test in Italy
SPA Farma, a leading pharmaceutical company of innovative healthcare products and diagnostic tools, and Inbiomotion, proprietors of MAF Test for identifying high risk early-stage breast
Ultrathin Graphene Brain Implant Was Just Tested in a Person
A Spanish biotech company sees the carbon material as a way to power the brain-computer interfaces of the future. Read more
Peptomyc Expands its Patent Portfolio with a Patent Grant in Hong Kong for its Methods and Composition for the Treatment of Cancer
Peptomyc S.L., a company developing foundational mini-protein therapeutics for the treatment of cancer, announces today that the Company has been issued a patent by the
Todosalud Incorporates Mediktor’s AI into Its Services as Part of Its Commitment to Innovation
Synergia Inversiones and Negocios S.A.S. are adding Mediktor’s advanced AI virtual assistant, called Frank, to its todosalud digital health platform. Users will have access to
Mediktor Acquires Sensely and Consolidates Its Position as a Leader in AI Healthcare Solutions
Mediktor, the leading digital healthcare company, has announced the acquisition of Sensely, a San Francisco-based, digital healthcare provider that pioneered an empathy-driven conversation platform to
